ClinVar Miner

Submissions for variant NM_001105206.3(LAMA4):c.1390C>G (p.His464Asp)

gnomAD frequency: 0.00010  dbSNP: rs151119304
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000037334 SCV000060991 uncertain significance not specified 2013-01-13 criteria provided, single submitter clinical testing Variant classified as Uncertain Significance - Favor Benign. The His457Asp varia nt in LAMA4 has not been reported in the literature, but has been identified by our laboratory in 1 individual with HCM, who also carried another variant likely to be disease-causing (LMM unpublished data). This variant is listed in dbSNP w ithout frequency information (dbSNP rs151119304) and has not been identified in large and broad European American and African American populations by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS), though it may be co mmon in other populations. Histidine (His) at position 457 is not well conserved in evolution, including in mammals, which suggests that a change at this positi on may be tolerated. Other computational analyses (biochemical amino acid proper ties, AlignGVGD, PolyPhen2, and SIFT) also suggest that the variant may not impa ct the protein, though this information is not predictive enough to rule out pat hogenicity. In summary, the available data suggests that this variant is more li kely benign, but additional studies are needed to fully assess the clinical sign ificance of the His457Asp variant.
Invitae RCV000651446 SCV000773297 uncertain significance Dilated cardiomyopathy 1JJ 2023-04-06 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant  is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 44346). This variant has not been reported in the literature in individuals affected with LAMA4-related conditions. This variant is present in population databases (rs151119304, gnomAD 0.01%). This sequence change replaces histidine, which is basic and polar, with aspartic acid, which is acidic and polar, at codon 457 of the LAMA4 protein (p.His457Asp).
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV001170697 SCV001333291 uncertain significance Cardiomyopathy 2018-09-11 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV000651446 SCV002785240 uncertain significance Dilated cardiomyopathy 1JJ 2021-08-12 criteria provided, single submitter clinical testing
Ambry Genetics RCV003298066 SCV003988566 uncertain significance Cardiovascular phenotype 2023-04-09 criteria provided, single submitter clinical testing The p.H457D variant (also known as c.1369C>G), located in coding exon 11 of the LAMA4 gene, results from a C to G substitution at nucleotide position 1369. The histidine at codon 457 is replaced by aspartic acid, an amino acid with similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV001725122 SCV001959996 likely benign not provided no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV001725122 SCV001969632 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.